ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
96,882.22
-5.30%
S&P 500
5,935.99
-0.66%
Dow Jones
42,660.40
-0.11%
US Dollar vs Yen
157.6435
-0.07%
Brent Oil
77.045
1.22%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Exelixis Inc (EXEL)

  7. Exelixis Inc (EXEL) ニュース

EXEL

Exelixis (EXEL)

Exelixis Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:EXEL
日付受信時刻ニュースソース見出しコード企業名
2025/01/0706 : 05Business WireExelixis to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025NASDAQ:EXELExelixis Inc
2024/12/2410 : 16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
2024/12/0310 : 29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
2024/11/3003 : 12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXELExelixis Inc
2024/11/2806 : 05Business WireExelixis to Webcast Fireside Chats as Part of Investor Conferences in DecemberNASDAQ:EXELExelixis Inc
2024/11/2709 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
2024/11/2706 : 05Business WireExelixis Provides Regulatory Update Related to Supplemental New Drug Application for Cabozantinib (CABOMETYX®) for the Treatment of Patients with Previously Treated Advanced Neuroendocrine TumorsNASDAQ:EXELExelixis Inc
2024/11/2306 : 01Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXELExelixis Inc
2024/11/2010 : 03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
2024/11/2010 : 03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
2024/11/2010 : 03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
2024/11/2010 : 03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
2024/11/2010 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
2024/11/2010 : 02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
2024/11/1908 : 50Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXELExelixis Inc
2024/11/1906 : 10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXELExelixis Inc
2024/11/0809 : 44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
2024/11/0806 : 05Business WireExelixis to Webcast Fireside Chats as Part of Investor Conferences in NovemberNASDAQ:EXELExelixis Inc
2024/11/0609 : 05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
2024/11/0609 : 04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
2024/11/0606 : 23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXELExelixis Inc
2024/11/0207 : 44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
2024/11/0207 : 43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
2024/11/0205 : 54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXELExelixis Inc
2024/11/0205 : 47Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXELExelixis Inc
2024/10/3107 : 04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EXELExelixis Inc
2024/10/3105 : 10Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EXELExelixis Inc
2024/10/3005 : 11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EXELExelixis Inc
2024/10/3005 : 07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EXELExelixis Inc
2024/10/3005 : 05Business WireExelixis Announces Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:EXELExelixis Inc
 Showing the most relevant articles for your search:NASDAQ:EXEL

最近閲覧した銘柄

COIN
ETHUSD
Ethereum
NASDAQ
MSFT
Microsoft
NASDAQ
AMZN
Amazon.com
SPI
SP500
S&P 500
NASDAQ
TSLA
Tesla
USI
USTECH100
US Tech 100
CCOM
US30
US 30
NYSE
VZ
Verizon Communications
COIN
SOLUSD
Solana
COIN
ADAUSD
Cardano
USOTC
RHHBY
Roche (QX)
USOTC
ADDYY
Adidas (QX)
NYSE
NKE
Nike
NASDAQ
GOOGL
Alphabet
NYSE
MRK
Merck
AMEX
XLE
Energy Select Sector SPDR
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有